Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

Good Law
United States District Court, Northern District of CaliforniaMay 8, 20204:17-cv-04405California1,298 words

Opinion

Trial Court Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA 6 PLEXXIKON INC., Case No. 17-cv-04405-HSG

Plaintiff, ORDER DENYING MOTION TO

EXCLUDE CERTAIN OPINIONS AND

v. TESTIMONY OF DEFENDANT'S

TECHNICAL EXPERTS

NOVARTIS PHARMACEUTICALS CORPORATION, Re: Dkt. No. 165 11 Defendant. 12 Pending before the Court is Plaintiff Plexxikon Inc.’s motion to exclude certain opinions and testimony of Defendant Novartis Pharmaceuticals Corporation’s technical experts. Dkt. No. 165. The Court heard argument on this motion on November 1, 2019. See Dkt. No. 341. As detailed below, the Court DENIES the motion. I. BACKGROUND Plaintiff challenges portions of the expert reports and the anticipated testimony of three of Defendant’s technical experts: Dr. Phil S. Baran; Dr. Swaminathan Natarajan; and Dr. Andrew Jennings. Dkt. No. 165. Plaintiff does not appear to question the credentials of the three experts, but instead contends that they have applied incorrect legal…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.